Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysis

International Urology and Nephrology 2026

View at publisher
Authors: Roberto Contieri, Letizia Maria Ippolita Jannello, Mihai Dorin Vartolomei, Beat Roth, R. Bianchi, Giuseppe Fallara, Marco Tozzi, Martina Maggi, Francesco Chierigo, Francesco Pellegrino, Ludovica Cella, A. Uleri
+49 more LUIGI FILIPPO DA POZZO, Francesco Claps, Achille Aveta, Gianluca Spena, Enrico Checcucci, Cecilia Gatti, Pierluigi Bove, F. Vedovo, Gian Maria Busetto, U G Falagario, Riccardo Mastroianni, Alessandro Tedde, Massimo Madonia, Pasquale Di Tonno, Giuseppe Tiziano Lucarelli, Saverio Forte, Giorgio Ivan Russo, Fabrizio Verweij, Marco Racioppi, Francesco Pio Bizzarri, Marco Borghesi, Marco Rinaldi, Fabio Zattoni, Luca Boeri, E. De Lorenzis, Andrea Conti, Maria Angela Cerruto, Felice Crocetto, Giuseppe Simone, Savino Mauro Di Stasi, Cosimo De NUNZIO, Luca Carmignani, Giovanni Liguori, Angelo Porreca, Biagio Barone, Emanuele Montanari, Albo Giancarlo, Alessandro Antonelli, Alessandro Veccia, Fabrizio Dal Moro, G Carrieri, Luigi Cormio, Carlo Terrone, Francesco Porpiglia, Sisto Perdonà, Bernardo Rocco, R. Hurle, Michele Catellani, Matteo Ferro
DOI: 10.1007/s11255-025-04946-9
Cited by: 1
References: 16

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Esophageal Cancer Research and Treatment Parathyroid Disorders and Treatments

Publication details

Journal / source
International Urology and Nephrology
Publisher
Springer Science and Business Media LLC
Volume
58
Issue
7
Pages
2463–2471
Publication date
2 January 2026
Language
EN